Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) EBT Margin (2016 - 2020)

Historic EBT Margin for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to 5226.32%.

  • Syndax Pharmaceuticals' EBT Margin fell 14881600.0% to 5226.32% in Q4 2020 from the same period last year, while for Dec 2020 it was 4708.17%, marking a year-over-year decrease of 9152300.0%. This contributed to the annual value of 1345.06% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Syndax Pharmaceuticals reported EBT Margin of 5226.32% as of Q4 2020, which was down 14881600.0% from 5238.26% recorded in Q3 2020.
  • Syndax Pharmaceuticals' 5-year EBT Margin high stood at 1594.89% for Q4 2017, and its period low was 5238.26% during Q3 2020.
  • For the 5-year period, Syndax Pharmaceuticals' EBT Margin averaged around 4162.45%, with its median value being 4309.0% (2017).
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 317537900bps in 2016, then plummeted by -34927400bps in 2018.
  • Quarter analysis of 5 years shows Syndax Pharmaceuticals' EBT Margin stood at 3564.92% in 2016, then soared by 55bps to 1594.89% in 2017, then plummeted by -219bps to 5087.63% in 2018, then rose by 27bps to 3738.16% in 2019, then crashed by -40bps to 5226.32% in 2020.
  • Its EBT Margin was 5226.32% in Q4 2020, compared to 5238.26% in Q3 2020 and 4382.59% in Q2 2020.